Saturday, 22nd January 2022
<To guardian.ng
Search
Breaking News:

COVID-19 mass vaccination aims to rapidly increase uptake of vaccines

By NAN
02 December 2021   |   11:03 am
The National Primary Health Care Development Agency (NPHCDA), says COVID-19 mass vaccination aims to increase uptake of the vaccine in Nigeria to rapidly achieve herd immunity.

A health worker tries to load into a syringe a Vaxzevria Astrazeneca vaccine during the vaccination of Muslim faithfuls against coronavirus (COVID-19) at the Secretariat Community Central Mosque, Alausa, Ikeja in Lagos, on November 26, 2021. – Fearing a surge in cases over Christmas travel season and wary of the emergence of new variants, Nigeria is turning to religious leaders, churches and mosques to push a mass vaccination campaign. (Photo by PIUS UTOMI EKPEI / AFP)

The National Primary Health Care Development Agency (NPHCDA), says COVID-19 mass vaccination aims to increase uptake of the vaccine in Nigeria to rapidly achieve herd immunity.

NPHCDA’s Executive Director, Dr Faisal Shuaib, says the mass vaccination campaign was an initiative of the agency, state governments and development partners.

He told the News Agency of Nigeria (NAN) on Thursday in Abuja that the move was meant to increase access and utilisation of COVID-19 vaccines.

He explained that the campaign would expand vaccination to public and private health facilities, pharmacies, COVID-19 diagnostic centres, and high human traffic public places such as shopping malls, markets and events centres.

“COVID-19 vaccination is not compulsory. However, with effect from Dec. 1, 2021, Federal Government employees shall be required to show proof of vaccination.

“They can also present negative COVID-19 PCR test results obtained within 72 hours to gain access into their offices,’’ he said.

He restated that COVID-19 vaccine is free, safe and effective and that recipients should take same type at the first and second rounds of vaccination.

Shuaib also restated that those who are 18 years and above should take the vaccines already approved by the WHO and NAFDAC.

In this article